Trial · NCT03518034
Adverse events2,668
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,668
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | DIABETES MELLITUS | Metabolism and nutrition disorders | AndroGel 1.62% Predose | 0 | 0 | |
| other | DIABETES MELLITUS | Metabolism and nutrition disorders | Placebo Predose | 0 | 0 | |
| other | DIABETES MELLITUS | Metabolism and nutrition disorders | AndroGel 1.62% | 160 | 2,596 | 169 |
| other | DIABETES MELLITUS | Metabolism and nutrition disorders | Placebo | 170 | 2,602 | 183 |
| serious | ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% Predose | 0 | 2,601 | 0 |
| serious | ANAEMIA | Blood and lymphatic system disorders | Placebo Predose | 0 | 2,603 | 0 |
| serious | ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% | 7 | 2,601 | 7 |
| serious | ANAEMIA | Blood and lymphatic system disorders | Placebo | 6 | 2,603 | 7 |
| serious | BLOOD LOSS ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% Predose | 0 | 2,601 | 0 |
| serious | BLOOD LOSS ANAEMIA | Blood and lymphatic system disorders | Placebo Predose | 0 | 2,603 | 0 |
| serious | BLOOD LOSS ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% | 2 | 2,601 | 2 |
| serious | BLOOD LOSS ANAEMIA | Blood and lymphatic system disorders | Placebo | 3 | 2,603 | 3 |
| serious | IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% Predose | 0 | 2,601 | 0 |
| serious | IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | Placebo Predose | 0 | 2,603 | 0 |
| serious | IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | AndroGel 1.62% | 0 | 2,601 | 0 |
| serious | IRON DEFICIENCY ANAEMIA | Blood and lymphatic system disorders | Placebo | 2 | 2,603 | 2 |
| serious | LEUKOCYTOSIS | Blood and lymphatic system disorders | AndroGel 1.62% Predose | 0 | 2,601 | 0 |
| serious | LEUKOCYTOSIS | Blood and lymphatic system disorders | Placebo Predose | 0 | 2,603 | 0 |
| serious | LEUKOCYTOSIS | Blood and lymphatic system disorders | AndroGel 1.62% | 0 | 2,601 | 0 |
| serious | LEUKOCYTOSIS | Blood and lymphatic system disorders | Placebo | 1 | 2,603 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03518034/events